Recommended management of lower respiratory tract infections
Identifieur interne : 001041 ( Istex/Corpus ); précédent : 001040; suivant : 001042Recommended management of lower respiratory tract infections
Auteurs : Sarah MeisnerSource :
- Prescriber [ 0959-6682 ] ; 2008-09-19.
English descriptors
- Teeft :
- Acute bronchitis, Acute exacerbation, Acute exacerbations, Aetiology, Aggressive strains, Amoxicillin, Antibiotic, Antibiotic therapy, Antimicrobial resistance, Atypical, Atypical organisms, Atypical pathogens, British thoracic society, British thoracic society guidelines, Broad spectrum, Bronchitis, Causative agents, Chronic bronchitis, Chronic disease, Chronic pneumonia, Churchill livingstone, Clinical knowledge summaries, Common infection, Copd, Core features, Cystic fibrosis, Empirical therapy, Erythromycin, Exacerbation, Fluoroquinolones, Funds research, Green book, Guideline, Health protection agency, Immunisation, Infectious diseases, Influenza, Influenza virus, Influenzae, Initial assessment, Intravenous therapy, Legionella species, Lrtis, Lung abscesses, Lung function, Macrolides, Mycoplasma, Newer fluoroquinolones, Newer macrolides, Other causes, Other viruses, Pathogen, Penicillin resistance, Pertussis, Pneumococcus, Pneumonia, Pneumoniae, Pregnant women, Prescriber, Preventive measures, Primary care, Pulmonary disease, Respiratory tract infections, Risk factors, September, Social circumstances, Sputum, Sputum production, Strep, Tetracycline, Tract infection, Tract infections, Viral, Wide range, Young children.
Abstract
Lower respiratory tract infections comprise a wide range of pathologies and causative pathogens that require differentiating in order to administer the most appropriate treatment. Our Drug review discusses the current recommended management of LRTIs in the community, followed by sources of further information in Resources. Copyright © 2008 Wiley Interface Ltd
Url:
DOI: 10.1002/psb.285
Links to Exploration step
ISTEX:36F2A574BBAF64B47C5D0D45BE266B0C9EB8A0D9Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Recommended management of lower respiratory tract infections</title><author><name sortKey="Meisner, Sarah" sort="Meisner, Sarah" uniqKey="Meisner S" first="Sarah" last="Meisner">Sarah Meisner</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:36F2A574BBAF64B47C5D0D45BE266B0C9EB8A0D9</idno><date when="2008" year="2008">2008</date><idno type="doi">10.1002/psb.285</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-3MMNJFHC-3/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001041</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001041</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Recommended management of lower respiratory tract infections</title><author><name sortKey="Meisner, Sarah" sort="Meisner, Sarah" uniqKey="Meisner S" first="Sarah" last="Meisner">Sarah Meisner</name></author></analytic><monogr></monogr><series><title level="j" type="main">Prescriber</title><title level="j" type="alt">PRESCRIBER</title><idno type="ISSN">0959-6682</idno><idno type="eISSN">1931-2253</idno><imprint><biblScope unit="vol">19</biblScope><biblScope unit="issue">18</biblScope><biblScope unit="page" from="21">21</biblScope><biblScope unit="page" to="40">40</biblScope><biblScope unit="page-count">12</biblScope><publisher>John Wiley & Sons, Ltd.</publisher><pubPlace>Chichester, UK</pubPlace><date type="published" when="2008-09-19">2008-09-19</date></imprint><idno type="ISSN">0959-6682</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0959-6682</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Acute bronchitis</term><term>Acute exacerbation</term><term>Acute exacerbations</term><term>Aetiology</term><term>Aggressive strains</term><term>Amoxicillin</term><term>Antibiotic</term><term>Antibiotic therapy</term><term>Antimicrobial resistance</term><term>Atypical</term><term>Atypical organisms</term><term>Atypical pathogens</term><term>British thoracic society</term><term>British thoracic society guidelines</term><term>Broad spectrum</term><term>Bronchitis</term><term>Causative agents</term><term>Chronic bronchitis</term><term>Chronic disease</term><term>Chronic pneumonia</term><term>Churchill livingstone</term><term>Clinical knowledge summaries</term><term>Common infection</term><term>Copd</term><term>Core features</term><term>Cystic fibrosis</term><term>Empirical therapy</term><term>Erythromycin</term><term>Exacerbation</term><term>Fluoroquinolones</term><term>Funds research</term><term>Green book</term><term>Guideline</term><term>Health protection agency</term><term>Immunisation</term><term>Infectious diseases</term><term>Influenza</term><term>Influenza virus</term><term>Influenzae</term><term>Initial assessment</term><term>Intravenous therapy</term><term>Legionella species</term><term>Lrtis</term><term>Lung abscesses</term><term>Lung function</term><term>Macrolides</term><term>Mycoplasma</term><term>Newer fluoroquinolones</term><term>Newer macrolides</term><term>Other causes</term><term>Other viruses</term><term>Pathogen</term><term>Penicillin resistance</term><term>Pertussis</term><term>Pneumococcus</term><term>Pneumonia</term><term>Pneumoniae</term><term>Pregnant women</term><term>Prescriber</term><term>Preventive measures</term><term>Primary care</term><term>Pulmonary disease</term><term>Respiratory tract infections</term><term>Risk factors</term><term>September</term><term>Social circumstances</term><term>Sputum</term><term>Sputum production</term><term>Strep</term><term>Tetracycline</term><term>Tract infection</term><term>Tract infections</term><term>Viral</term><term>Wide range</term><term>Young children</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Lower respiratory tract infections comprise a wide range of pathologies and causative pathogens that require differentiating in order to administer the most appropriate treatment. Our Drug review discusses the current recommended management of LRTIs in the community, followed by sources of further information in Resources. Copyright © 2008 Wiley Interface Ltd</div></front></TEI><istex><corpusName>wiley</corpusName><keywords><teeft><json:string>pneumoniae</json:string><json:string>antibiotic</json:string><json:string>lrtis</json:string><json:string>strep</json:string><json:string>bronchitis</json:string><json:string>influenzae</json:string><json:string>september</json:string><json:string>erythromycin</json:string><json:string>prescriber</json:string><json:string>aetiology</json:string><json:string>pneumococcus</json:string><json:string>sputum</json:string><json:string>pertussis</json:string><json:string>guideline</json:string><json:string>pathogen</json:string><json:string>amoxicillin</json:string><json:string>tetracycline</json:string><json:string>copd</json:string><json:string>immunisation</json:string><json:string>macrolides</json:string><json:string>viral</json:string><json:string>acute bronchitis</json:string><json:string>fluoroquinolones</json:string><json:string>mycoplasma</json:string><json:string>antibiotic therapy</json:string><json:string>influenza</json:string><json:string>pneumonia</json:string><json:string>chronic pneumonia</json:string><json:string>health protection agency</json:string><json:string>atypical</json:string><json:string>tract infections</json:string><json:string>newer fluoroquinolones</json:string><json:string>infectious diseases</json:string><json:string>sputum production</json:string><json:string>antimicrobial resistance</json:string><json:string>pregnant women</json:string><json:string>atypical pathogens</json:string><json:string>cystic fibrosis</json:string><json:string>pulmonary disease</json:string><json:string>core features</json:string><json:string>exacerbation</json:string><json:string>penicillin resistance</json:string><json:string>social circumstances</json:string><json:string>causative agents</json:string><json:string>wide range</json:string><json:string>lung abscesses</json:string><json:string>aggressive strains</json:string><json:string>green book</json:string><json:string>empirical therapy</json:string><json:string>british thoracic society</json:string><json:string>influenza virus</json:string><json:string>atypical organisms</json:string><json:string>other viruses</json:string><json:string>legionella species</json:string><json:string>newer macrolides</json:string><json:string>chronic disease</json:string><json:string>risk factors</json:string><json:string>lung function</json:string><json:string>acute exacerbation</json:string><json:string>acute exacerbations</json:string><json:string>common infection</json:string><json:string>primary care</json:string><json:string>clinical knowledge summaries</json:string><json:string>tract infection</json:string><json:string>young children</json:string><json:string>chronic bronchitis</json:string><json:string>preventive measures</json:string><json:string>intravenous therapy</json:string><json:string>british thoracic society guidelines</json:string><json:string>initial assessment</json:string><json:string>broad spectrum</json:string><json:string>churchill livingstone</json:string><json:string>funds research</json:string><json:string>respiratory tract infections</json:string><json:string>other causes</json:string></teeft></keywords><author><json:item><name>Sarah Meisner PhD, MRCP, MRCPath, DTM&H</name></json:item></author><articleId><json:string>PSB285</json:string></articleId><arkIstex>ark:/67375/WNG-3MMNJFHC-3</arkIstex><language><json:string>eng</json:string></language><originalGenre><json:string>miscellaneous</json:string></originalGenre><abstract>Lower respiratory tract infections comprise a wide range of pathologies and causative pathogens that require differentiating in order to administer the most appropriate treatment. Our Drug review discusses the current recommended management of LRTIs in the community, followed by sources of further information in Resources. Copyright © 2008 Wiley Interface Ltd</abstract><qualityIndicators><score>7.612</score><pdfWordCount>5014</pdfWordCount><pdfCharCount>34832</pdfCharCount><pdfVersion>1.3</pdfVersion><pdfPageCount>12</pdfPageCount><pdfPageSize>595 x 780 pts</pdfPageSize><pdfWordsPerPage>418</pdfWordsPerPage><pdfText>true</pdfText><refBibsNative>false</refBibsNative><abstractWordCount>51</abstractWordCount><abstractCharCount>361</abstractCharCount><keywordCount>0</keywordCount></qualityIndicators><title>Recommended management of lower respiratory tract infections</title><genre><json:string>article</json:string></genre><host><title>Prescriber</title><language><json:string>unknown</json:string></language><doi><json:string>10.1002/(ISSN)1931-2253</json:string></doi><issn><json:string>0959-6682</json:string></issn><eissn><json:string>1931-2253</json:string></eissn><publisherId><json:string>PSB</json:string></publisherId><volume>19</volume><issue>18</issue><pages><first>21</first><last>40</last><total>12</total></pages><genre><json:string>journal</json:string></genre><subject><json:item><value>Drug Review</value></json:item><json:item><value>Drug Reviews</value></json:item></subject></host><namedEntities><unitex><date><json:string>2000</json:string><json:string>18s</json:string><json:string>2001</json:string><json:string>65s</json:string><json:string>2006</json:string><json:string>2008</json:string><json:string>2004</json:string></date><geogName></geogName><orgName></orgName><orgName_funder></orgName_funder><orgName_provider></orgName_provider><persName><json:string>Studies</json:string><json:string>Drug</json:string><json:string>Sarah Meisner</json:string></persName><placeName><json:string>UK</json:string><json:string>Ireland</json:string><json:string>Italy</json:string></placeName><ref_url></ref_url><ref_bibl></ref_bibl><bibl></bibl></unitex></namedEntities><ark><json:string>ark:/67375/WNG-3MMNJFHC-3</json:string></ark><categories><inist><json:string>1 - sciences appliquees, technologies et medecines</json:string><json:string>2 - sciences biologiques et medicales</json:string><json:string>3 - sciences medicales</json:string></inist></categories><publicationDate>2008</publicationDate><copyrightDate>2008</copyrightDate><doi><json:string>10.1002/psb.285</json:string></doi><id>36F2A574BBAF64B47C5D0D45BE266B0C9EB8A0D9</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-3MMNJFHC-3/fulltext.pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-3MMNJFHC-3/bundle.zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/WNG-3MMNJFHC-3/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main">Recommended management of lower respiratory tract infections</title><title level="a" type="short" xml:lang="en">LRTIs</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>John Wiley & Sons, Ltd.</publisher><pubPlace>Chichester, UK</pubPlace><availability><licence>Copyright © 2008 Wiley Interface Ltd</licence></availability><date type="published" when="2008-09-19"></date></publicationStmt><notesStmt><note type="content-type" subtype="other" source="miscellaneous" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-7474895G-0">other</note><note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note></notesStmt><sourceDesc><biblStruct type="other"><analytic><title level="a" type="main">Recommended management of lower respiratory tract infections</title><title level="a" type="short" xml:lang="en">LRTIs</title><author xml:id="author-0000"><persName><forename type="first">Sarah</forename><surname>Meisner</surname><roleName type="degree">PhD, MRCP, MRCPath, DTM&H</roleName></persName></author><idno type="istex">36F2A574BBAF64B47C5D0D45BE266B0C9EB8A0D9</idno><idno type="ark">ark:/67375/WNG-3MMNJFHC-3</idno><idno type="DOI">10.1002/psb.285</idno><idno type="unit">PSB285</idno><idno type="toTypesetVersion">file:PSB.PSB285.pdf</idno></analytic><monogr><title level="j" type="main">Prescriber</title><title level="j" type="alt">PRESCRIBER</title><idno type="pISSN">0959-6682</idno><idno type="eISSN">1931-2253</idno><idno type="book-DOI">10.1002/(ISSN)1931-2253</idno><idno type="book-part-DOI">10.1002/psb.v19:18</idno><idno type="product">PSB</idno><imprint><biblScope unit="vol">19</biblScope><biblScope unit="issue">18</biblScope><biblScope unit="page" from="21">21</biblScope><biblScope unit="page" to="40">40</biblScope><biblScope unit="page-count">12</biblScope><publisher>John Wiley & Sons, Ltd.</publisher><pubPlace>Chichester, UK</pubPlace><date type="published" when="2008-09-19"></date></imprint></monogr></biblStruct></sourceDesc></fileDesc><encodingDesc><schemaRef type="ODD" url="https://xml-schema.delivery.istex.fr/tei-istex.odd"></schemaRef><appInfo><application ident="pub2tei" version="1.0.10" when="2019-12-20"><label>pub2TEI-ISTEX</label><desc>A set of style sheets for converting XML documents encoded in various scientific publisher formats into a common TEI format.
<ref target="http://www.tei-c.org/">We use TEI</ref></desc></application></appInfo></encodingDesc><profileDesc><abstract xml:lang="en" style="main"><head>Abstract</head><p>Lower respiratory tract infections comprise a wide range of pathologies and causative pathogens that require differentiating in order to administer the most appropriate treatment. Our Drug review discusses the current recommended management of LRTIs in the community, followed by sources of further information in Resources. Copyright © 2008 Wiley Interface Ltd</p></abstract><textClass><keywords rend="articleCategory"><term>Drug Review</term></keywords><keywords rend="tocHeading1"><term>Drug Reviews</term></keywords></textClass><langUsage><language ident="en"></language></langUsage></profileDesc><revisionDesc><change when="2019-12-20" who="#istex" xml:id="pub2tei">formatting</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-3MMNJFHC-3/fulltext.txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley component found"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>John Wiley & Sons, Ltd.</publisherName><publisherLoc>Chichester, UK</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1931-2253</doi><issn type="print">0959-6682</issn><issn type="electronic">1931-2253</issn><idGroup><id type="product" value="PSB"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="PRESCRIBER">Prescriber</title><title type="short">Prescriber</title></titleGroup></publicationMeta><publicationMeta level="part" position="180"><doi origin="wiley" registered="yes">10.1002/psb.v19:18</doi><numberingGroup><numbering type="journalVolume" number="19">19</numbering><numbering type="journalIssue">18</numbering></numberingGroup><coverDate startDate="2008-09-19">19 September 2008</coverDate></publicationMeta><publicationMeta level="unit" type="miscellaneous" position="3" status="forIssue"><doi origin="wiley" registered="yes">10.1002/psb.285</doi><idGroup><id type="unit" value="PSB285"></id></idGroup><countGroup><count type="pageTotal" number="12"></count></countGroup><titleGroup><title type="articleCategory">Drug Review</title><title type="tocHeading1">Drug Reviews</title></titleGroup><copyright ownership="publisher">Copyright © 2008 Wiley Interface Ltd</copyright><eventGroup><event type="firstOnline" date="2008-10-03"></event><event type="publishedOnlineFinalForm" date="2008-10-03"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.2 mode:FullText source:Header result:Header" date="2010-03-04"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-07"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-11-03"></event></eventGroup><numberingGroup><numbering type="pageFirst">21</numbering><numbering type="pageLast">40</numbering></numberingGroup><linkGroup><link type="toTypesetVersion" href="file:PSB.PSB285.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="1"></count><count type="tableTotal" number="3"></count><count type="referenceTotal" number="25"></count></countGroup><titleGroup><title type="main" xml:lang="en">Recommended management of lower respiratory tract infections</title><title type="short" xml:lang="en">LRTIs</title></titleGroup><creators><creator xml:id="au1" creatorRole="author"><personName><givenNames>Sarah</givenNames><familyName>Meisner</familyName><degrees>PhD, MRCP, MRCPath, DTM&H</degrees></personName></creator></creators><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>Lower respiratory tract infections comprise a wide range of pathologies and causative pathogens that require differentiating in order to administer the most appropriate treatment. Our Drug review discusses the current recommended management of LRTIs in the community, followed by sources of further information in Resources. Copyright © 2008 Wiley Interface Ltd</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Recommended management of lower respiratory tract infections</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>LRTIs</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Recommended management of lower respiratory tract infections</title></titleInfo><name type="personal"><namePart type="given">Sarah</namePart><namePart type="family">Meisner</namePart><namePart type="termsOfAddress">PhD, MRCP, MRCPath, DTM&H</namePart><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="article" displayLabel="miscellaneous" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-6N5SZHKN-D">article</genre><originInfo><publisher>John Wiley & Sons, Ltd.</publisher><place><placeTerm type="text">Chichester, UK</placeTerm></place><dateIssued encoding="w3cdtf">2008-09-19</dateIssued><copyrightDate encoding="w3cdtf">2008</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><extent unit="figures">1</extent><extent unit="tables">3</extent><extent unit="references">25</extent></physicalDescription><abstract lang="en">Lower respiratory tract infections comprise a wide range of pathologies and causative pathogens that require differentiating in order to administer the most appropriate treatment. Our Drug review discusses the current recommended management of LRTIs in the community, followed by sources of further information in Resources. Copyright © 2008 Wiley Interface Ltd</abstract><relatedItem type="host"><titleInfo><title>Prescriber</title></titleInfo><titleInfo type="abbreviated"><title>Prescriber</title></titleInfo><genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre><subject><genre>article-category</genre><topic>Drug Review</topic><topic>Drug Reviews</topic></subject><identifier type="ISSN">0959-6682</identifier><identifier type="eISSN">1931-2253</identifier><identifier type="DOI">10.1002/(ISSN)1931-2253</identifier><identifier type="PublisherID">PSB</identifier><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><detail type="issue"><caption>no.</caption><number>18</number></detail><extent unit="pages"><start>21</start><end>40</end><total>12</total></extent></part></relatedItem><identifier type="istex">36F2A574BBAF64B47C5D0D45BE266B0C9EB8A0D9</identifier><identifier type="ark">ark:/67375/WNG-3MMNJFHC-3</identifier><identifier type="DOI">10.1002/psb.285</identifier><identifier type="ArticleID">PSB285</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2008 Wiley Interface Ltd</accessCondition><recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-L0C46X92-X">wiley</recordContentSource><recordOrigin>Converted from (version ) to MODS version 3.6.</recordOrigin><recordCreationDate encoding="w3cdtf">2019-11-16</recordCreationDate></recordInfo></mods><json:item><extension>json</extension><original>false</original><mimetype>application/json</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-3MMNJFHC-3/record.json</uri></json:item></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001041 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001041 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:36F2A574BBAF64B47C5D0D45BE266B0C9EB8A0D9
|texte= Recommended management of lower respiratory tract infections
}}
| This area was generated with Dilib version V0.6.33. |  |